Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 20, 2015 - Issue 1
Submit an article Journal homepage
528
Views
12
CrossRef citations to date
0
Altmetric
Review

Emerging drugs for squamous cell lung cancer

Haiying ChengMontefiore Medical Center/Albert Einstein College of Medicine, Department of Oncology, 111 East 210th Street, NY 10467, [email protected]
,
Marina ShcherbaMontefiore Medical Center/Albert Einstein College of Medicine, Department of Oncology, 111 East 210th Street, NY 10467, [email protected]
,
Karthikeya KandavelouMontefiore Medical Center/Albert Einstein College of Medicine, Department of Oncology, 111 East 210th Street, NY 10467, [email protected]
,
Yuanxin LiangAlbert Einstein College of Medicine – Oncology, 1300 Morris Park Avenue, Bronx, NY 10461, USA
,
Huijie LiuAlbert Einstein College of Medicine – Oncology, 1300 Morris Park Avenue, Bronx, NY 10461, USA
&
Roman Perez-SolerMontefiore Medical Center/Albert Einstein College of Medicine, Department of Oncology, 111 East 210th Street, NY 10467, [email protected]
, MD
Pages 149-160 | Published online: 05 Jan 2015

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Chiara Lazzari, Niki Karachaliou, Vanesa Gregorc, Alessandra Bulotta, Maria Gonzalez-Cao, Alberto Verlicchi, Giuseppe Altavilla, Rafael Rosell & Mariacarmela Santarpia. (2017) Second-line therapy of squamous non-small cell lung cancer: an evolving landscape. Expert Review of Respiratory Medicine 11:6, pages 469-479.
Read now

Articles from other publishers (11)

Y Cao, R Zhang, X Luo & Y Yang. (2020) LncRNA PART1 promotes lung squamous cell carcinoma progression via miR-185-5p/Six1 axis. Human & Experimental Toxicology 40:6, pages 960-976.
Crossref
Xiran He, Yang Du, Zhijie Wang, Xin Wang, Jianchun Duan, Rui Wan, Jiachen Xu, Pei Zhang, Di Wang, Yanhua Tian, Jiefei Han, Kailun Fei, Hua Bai, Jie Tian & Jie Wang. (2020) Upfront dose-reduced chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinoma. Journal for ImmunoTherapy of Cancer 8:2, pages e000807.
Crossref
Longsheng Xu, Ying Zheng, Jingyu Wang, Yufen Xu, Yonghong Xie & Zhi-Ping Yang. (2020) IL33 activates CD8+T and NK cells through MyD88 pathway to suppress the lung cancer cell growth in mice. Biotechnology Letters 42:7, pages 1113-1121.
Crossref
Fei Guo, Dexiao Yuan, Junling Zhang, Hang Zhang, Chen Wang, Lin Zhu, Jianghong Zhang, Yan Pan & Chunlin Shao. (2019) Silencing of ARL14 Gene Induces Lung Adenocarcinoma Cells to a Dormant State. Frontiers in Cell and Developmental Biology 7.
Crossref
Bin Liu, Zheng Wang, Shizhao Cheng, Lin Du, Yan Yin, Zhen Yang & Jingmin Zhou. (2019) miR‑379 inhibits cell proliferation and epithelial‑mesenchymal transition by targeting CHUK through the NF‑κB pathway in non‑small cell lung cancer. Molecular Medicine Reports.
Crossref
Xiaofeng Xue, Xiaoyan Fei, Wenjie Hou, Yajie Zhang, Liu Liu & Rongkuan Hu. (2018) miR-342-3p suppresses cell proliferation and migration by targeting AGR2 in non-small cell lung cancer. Cancer Letters 412, pages 170-178.
Crossref
Haiying Cheng, Murali Janakiram, Alain Borczuk, Juan Lin, Wanglong Qiu, Huijie Liu, Jordan M. Chinai, Balazs Halmos, Roman Perez-Soler & Xingxing Zang. (2017) HHLA2, a New Immune Checkpoint Member of the B7 Family, Is Widely Expressed in Human Lung Cancer and Associated with EGFR Mutational Status. Clinical Cancer Research 23:3, pages 825-832.
Crossref
Chiara Lazzari, Alessandra Bulotta, Monika Ducceschi, Maria Grazia Viganò, Elena Brioschi, Francesca Corti, Luca Gianni & Vanesa Gregorc. (2017) Historical Evolution of Second-Line Therapy in Non-Small Cell Lung Cancer. Frontiers in Medicine 4.
Crossref
Catherine W. Bennett, Guy Berchem, Yeoun Jin Kim & Victoria El-Khoury. (2016) Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer. Oncotarget 7:43, pages 71013-71035.
Crossref
Chiara Lazzari, Alberto Verlicchi, Anastasios Gkountakos, Sara Pilotto, Mariacarmela Santarpia, Imane Chaib, Jose Luis Ramirez Serrano, Santiago Viteri, Daniela Morales-Espinosa, Claudio Dazzi, Filippo de Marinis, Peng Cao, Niki Karachaliou & Rafael Rosell. (2016) Molecular Bases for Combinatorial Treatment Strategies in Patients with KRAS Mutant Lung Adenocarcinoma and Squamous Cell Lung Carcinoma. Pulmonary Therapy 2:1, pages 1-18.
Crossref
Rongkuan Hu, Kenneth E. Huffman, Michael Chu, Yajie Zhang, John D. Minna & Yonghao Yu. (2016) Quantitative Secretomic Analysis Identifies Extracellular Protein Factors That Modulate the Metastatic Phenotype of Non-Small Cell Lung Cancer. Journal of Proteome Research 15:2, pages 477-486.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.